Answers are grounded in this paper and cite their sources.
Transcatheter mitral valve-in-valve replacement offers a less-invasive alternative for high-risk patients with bioprosthetic valve failure. Limited experience exists in intermediate-risk patients. We aim to evaluate 1-year outcomes of the PARTNER 3 mitral valve-in-valve study.
No takes yet. Share an insight, caveat, or question.
Malaisrie et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: